Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06538233 · ClinicalTrials.gov registry record · Phase 2
Pain After Buffered Vs Non Buffered Articaine
A Phase 2 study of Pain, sponsored by Cleveland Dental Institute.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06538233 is a Phase 2 study of Pain that is actively recruiting participants, run by Cleveland Dental Institute. The registered enrollment target is 108 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06538233, a Phase 2 study of Pain, is actively recruiting participants, sponsored by Cleveland Dental Institute.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
Pain after buffered versus non buffered articaine.
Conditions Studied
Interventions
- DRUG Buffered articaine
- DRUG Non buffered articaine
Study Locations (1)
Ohio
- Clevland Dental Institute - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2025-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06538233
The ClinicalTrials.gov registry entry for NCT06538233 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (64% lower). The listed sponsor is Cleveland Dental Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Buffered articaine is the first listed.
NCT06538233 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06538233 about?
NCT06538233 is a clinical study titled "Pain After Buffered Vs Non Buffered Articaine". Pain after buffered versus non buffered articaine.
What is the current status of trial NCT06538233?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2024-01-01. Estimated completion is 2025-01-31.
What conditions does trial NCT06538233 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT06538233?
The interventions under investigation include: Buffered articaine (DRUG), Non buffered articaine (DRUG).
Who is sponsoring clinical trial NCT06538233?
This trial is sponsored by Cleveland Dental Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06538233 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.